Twin Lakes Capital Management’s Pacific Biosciences PACB Stock Holding History

Twin Lakes Capital Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.52K	Hold	5,669	–	–	﹤0.01%	174
2026 Q1	$7.48K	Sell	5,669 -5,888	-51%	-$10.5K	﹤0.01%	190
2025 Q4	$21.6K	Hold	11,557	–	–	0.01%	172
2025 Q3	$14.8K	Hold	11,557	–	–	0.01%	179
2025 Q2	$14.3K	Hold	11,557	–	–	0.01%	174
2025 Q1	$13.6K	Hold	11,557	–	–	0.01%	177
2024 Q4	$21.1K	Sell	11,557 -2,713	-19%	-$5.3K	0.01%	177
2024 Q3	$24.3K	Hold	14,270	–	–	0.02%	171
2024 Q2	$19.6K	Hold	14,270	–	–	0.01%	175
2024 Q1	$53.5K	Hold	14,270	–	–	0.04%	135
2023 Q4	$140K	Hold	14,270	–	–	0.1%	92
2023 Q3	$119K	Hold	14,270	–	–	0.09%	98
2023 Q2	$190K	Hold	14,270	–	–	0.13%	85
2023 Q1	$165K	Hold	14,270	–	–	0.12%	93
2022 Q4	$117K	Hold	14,270	–	–	0.09%	101
2022 Q3	$83K	Buy	+14,270	New	+$81.9K	0.07%	108
2022 Q2	–	Sell	-14,270	Closed	-$130K	–	243
2022 Q1	$130K	Buy	14,270 +929	+7%	+$10.7K	0.07%	106
2021 Q4	$273K	Hold	13,341	–	–	0.15%	86
2021 Q3	$341K	Sell	13,341 -2,454	-16%	-$72.7K	0.2%	68
2021 Q2	$552K	Sell	15,795 -3,572	-18%	-$104K	0.31%	53
2021 Q1	$645K	Sell	19,367 -989	-5%	-$34.6K	0.4%	47
2020 Q4	$528K	Buy	+20,356	New	+$346K	0.38%	54

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Twin Lakes Capital Management's PACB Position: Q2 2026 in Review

Twin Lakes Capital Management held its Pacific Biosciences (PACB) position steady in Q2 2026 at 5,669 shares worth $9.52K. The position accounts for ﹤0.01% of the portfolio, ranked #174.

Twin Lakes Capital Management first reported a position in PACB in Q4 2020 and has held it in 22 quarters since. The position peaked at $645K in Q1 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Twin Lakes Capital Management held 5,669 shares of Pacific Biosciences worth $9.52K as of Q2 2026.
Twin Lakes Capital Management left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Twin Lakes Capital Management's portfolio in Q2 2026, its #174 holding.
Twin Lakes Capital Management first reported a position in Pacific Biosciences in Q4 2020 and has held it in 22 quarters since.
Twin Lakes Capital Management's Pacific Biosciences position peaked at $645K in Q1 2021.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.